Found: 114
Select item for more details and to access through your institution.
Diagnostic criteria for primary progressive multiple sclerosis: a position paper.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Primary progressive multiple sclerosis.
- Published in:
- 1997
- By:
- Publication type:
- journal article
P.048 International MAGNIMS-CMSC-NAIMS consensus recommendations on the use of standardized MRI in MS.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
P.048 International MAGNIMS-CMSC-NAIMS consensus recommendations on the use of standardized MRI in MS.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Implication of the toll-like receptor 4 pathway in the response to interferon-[beta] in multiple sclerosis.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
Is optic neuritis more benign than other first attacks in multiple sclerosis?
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis.
- Published in:
- Annals of Neurology, 2004, v. 56, n. 2, p. 273
- By:
- Publication type:
- Article
Diagnostic criteria for primary progressive multiple sclerosis: A position paper.
- Published in:
- Annals of Neurology, 2000, v. 47, n. 6, p. 831, doi. 10.1002/1531-8249(200006)47:6<831::AID-ANA21>3.0.CO;2-H
- By:
- Publication type:
- Article
Amelioration of flulike symptoms at the onset of interferon β- 1b therapy in multiple sclerosis by low-dose oral steroids is related to a decrease in interleukin-6 induction.
- Published in:
- Annals of Neurology, 1998, v. 44, n. 4, p. 682, doi. 10.1002/ana.410440415
- By:
- Publication type:
- Article
Metallothionein expression in the central nervous system of multiple sclerosis patients.
- Published in:
- Cellular & Molecular Life Sciences, 2003, v. 60, n. 6, p. 1258, doi. 10.1007/s00018-003-3021-z
- By:
- Publication type:
- Article
Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis.
- Published in:
- Cellular & Molecular Life Sciences, 2003, v. 60, n. 1, p. 185, doi. 10.1007/s000180300013
- By:
- Publication type:
- Article
A longitudinal study of cognition in primary progressive multiple sclerosis.
- Published in:
- Brain: A Journal of Neurology, 2005, v. 128, n. 12, p. 2891, doi. 10.1093/brain/awh602
- By:
- Publication type:
- Article
Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Primary progressive multiple sclerosis.
- Published in:
- Brain: A Journal of Neurology, 1997, v. 120, n. 6, p. 1085, doi. 10.1093/brain/120.6.1085
- By:
- Publication type:
- Article
Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.
- Published in:
- Neuroradiology, 2016, v. 58, n. 5, p. 467, doi. 10.1007/s00234-016-1654-5
- By:
- Publication type:
- Article
The basal ganglia: a substrate for fatigue in multiple sclerosis.
- Published in:
- Neuroradiology, 2008, v. 50, n. 1, p. 17, doi. 10.1007/s00234-007-0304-3
- By:
- Publication type:
- Article
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis.
- Published in:
- Genes & Immunity, 2012, v. 13, n. 5, p. 443, doi. 10.1038/gene.2012.18
- By:
- Publication type:
- Article
ANKRD55 and DHCR7 are novel multiple sclerosis risk loci.
- Published in:
- Genes & Immunity, 2012, v. 13, n. 3, p. 253, doi. 10.1038/gene.2011.81
- By:
- Publication type:
- Article
A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis.
- Published in:
- Genes & Immunity, 2012, v. 13, n. 1, p. 21, doi. 10.1038/gene.2011.44
- By:
- Publication type:
- Article
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis.
- Published in:
- Genes & Immunity, 2011, v. 12, n. 6, p. 466, doi. 10.1038/gene.2011.18
- By:
- Publication type:
- Article
Replication of top markers of a genome-wide association study in multiple sclerosis in Spain.
- Published in:
- Genes & Immunity, 2011, v. 12, n. 2, p. 110, doi. 10.1038/gene.2010.52
- By:
- Publication type:
- Article
Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis.
- Published in:
- Genes & Immunity, 2003, v. 4, n. 2, p. 147, doi. 10.1038/sj.gene.6363946
- By:
- Publication type:
- Article
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 8, p. 912, doi. 10.1177/1352458519845844
- By:
- Publication type:
- Article
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 7, p. 901, doi. 10.1177/1352458515607650
- By:
- Publication type:
- Article
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 13, p. 1632, doi. 10.1177/1352458515599848
- By:
- Publication type:
- Article
Brain atrophy in natalizumab-treated patients: A 3-year follow-up.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 749, doi. 10.1177/1352458514556300
- By:
- Publication type:
- Article
Significant clinical worsening after natalizumab withdrawal: Predictive factors.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 6, p. 780, doi. 10.1177/1352458514549401
- By:
- Publication type:
- Article
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 7, p. 877, doi. 10.1177/1352458513513059
- By:
- Publication type:
- Article
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 6, p. 717, doi. 10.1177/1352458513508835
- By:
- Publication type:
- Article
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 5, p. 577, doi. 10.1177/1352458513503597
- By:
- Publication type:
- Article
Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 1, p. 72, doi. 10.1177/1352458513492245
- By:
- Publication type:
- Article
Clinical impact of early brain atrophy in clinically isolated syndromes.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 14, p. 1878, doi. 10.1177/1352458513488231
- By:
- Publication type:
- Article
Scoring treatment response in patients with relapsing multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 5, p. 605, doi. 10.1177/1352458512460605
- By:
- Publication type:
- Article
SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 5, p. 524, doi. 10.1177/1352458512458718
- By:
- Publication type:
- Article
Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 2, p. 245, doi. 10.1177/1352458512444751
- By:
- Publication type:
- Article
Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 7, p. 966, doi. 10.1177/1352458511432327
- By:
- Publication type:
- Article
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 7, p. 983, doi. 10.1177/1352458511433063
- By:
- Publication type:
- Article
Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 11, p. 1341, doi. 10.1177/1352458511411061
- By:
- Publication type:
- Article
A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 4, p. 457, doi. 10.1177/1352458510389219
- By:
- Publication type:
- Article
Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry.
- Published in:
- PLoS ONE, 2021, v. 16, n. 10, p. 1, doi. 10.1371/journal.pone.0258437
- By:
- Publication type:
- Article
Clinical features of CIS of the brainstem/cerebellum of the kind seen in MS.
- Published in:
- Journal of Neurology, 2010, v. 257, n. 5, p. 742, doi. 10.1007/s00415-009-5403-0
- By:
- Publication type:
- Article
Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis.
- Published in:
- Journal of Neurology, 2008, v. 255, n. 8, p. 1136, doi. 10.1007/s00415-008-0855-1
- By:
- Publication type:
- Article
MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain.
- Published in:
- Journal of Neurology, 2008, v. 255, n. 1, p. 1, doi. 10.1007/s00415-007-0754-x
- By:
- Publication type:
- Article
Interferon beta in secondary progressive multiple sclerosis.
- Published in:
- Journal of Neurology, 2007, v. 254, n. 7, p. 849, doi. 10.1007/s00415-006-0477-4
- By:
- Publication type:
- Article
Fatigue in multiple sclerosis persists over time.
- Published in:
- Journal of Neurology, 2006, v. 253, n. 11, p. 1466, doi. 10.1007/s00415-006-0247-3
- By:
- Publication type:
- Article
Reply to D. S. Goodin.
- Published in:
- Journal of Neurology, 2006, v. 253, n. 7, p. 949, doi. 10.1007/s00415-006-0098-y
- By:
- Publication type:
- Article
CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS.
- Published in:
- Journal of Neurology, 2004, v. 251, n. 10, p. 1278, doi. 10.1007/s00415-004-0524-y
- By:
- Publication type:
- Article
Clinically definite multiple sclerosis after radiological Schilder-like onset.
- Published in:
- Journal of Neurology, 2003, v. 250, n. 7, p. 871, doi. 10.1007/s00415-003-1105-1
- By:
- Publication type:
- Article